Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,860
Closed -$224K 119
2026
Q1
$224K Buy
+1,860
New +$215K 0.07% 108
2025
Q1
Sell
-2,160
Closed -$215K 99
2024
Q4
$215K Buy
+2,160
New +$223K 0.15% 92

Other funds holding MRK

L.K. Benson & Company's MRK Position: Q2 2026 in Review

L.K. Benson & Company sold out of Merck (MRK) in Q2 2026, closing a stake of 1,860 shares — an estimated $224K sold.

L.K. Benson & Company first reported a position in MRK in Q4 2024 and held it in 2 quarters. The position peaked at $224K in Q1 2026. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • L.K. Benson & Company reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • L.K. Benson & Company sold 1,860 Merck shares in Q2 2026, an estimated $224K.
  • L.K. Benson & Company first reported a position in Merck in Q4 2024 and held it in 2 quarters.
  • L.K. Benson & Company's Merck position peaked at $224K in Q1 2026.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on L.K. Benson & Company's 13F filing for Q2 2026, filed 24 Jul 2026.